Where I see patients (2)
My reviews
Selected research
-
Initial Experience with 68Ga-FAP-2286 PET Imaging in Patients with Urothelial Cancer.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine
-
Immune modulation with RANKL blockade through denosumab treatment in patients with cancer.
Cancer immunology research
-
Patient-Reported Outcomes in Patients With Advanced Urothelial Cancer Who Are Ineligible for Cisplatin and Treated With First-Line Enfortumab Vedotin Alone or With Pembrolizumab.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Clinical trials
Study Evaluating the Efficacy and Safety of Multiple Immunotherapy-Based Treatments and Combina...
Objective response rate, defined as the proportion of participants with a CR or PR on two consecutive occasions >=4 weeks apart during Stage 1, as determined by the investigator according to RECIST v1.1.
Recruiting
Duloxetine to Prevent Oxaliplatin-Induced Peripheral Neuropathy in Patients With Stage II-III C...
Will be measured using 6 individual Quality of Life Questionnaire - Chemotherapy-Induced Peripheral Neuropathy 20 (QLQ-CIPN20) questions that quantify numbness, tingling, and pain in the fingers (or hands) and toes (or feet). For ...
Recruiting
5.0